Will Demand for Rapid COVID-19 Tests Help Abbott Laboratories Beat the Market in 2022?The Motley Fool • 01/16/22
Abbott Receives U.S. FDA Clearance for New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart RhythmsPRNewsWire • 01/12/22
Abbott Laboratories (ABT) CEO Robert Ford Presents at JPMorgan 40th Annual Healthcare Brokers Conference (Transcript)Seeking Alpha • 01/11/22
Abbott's Proclaim™ XR Spinal Cord Stimulation System Now Offers Expanded MRI Compatibility in U.S.PRNewsWire • 01/04/22